Consolidated Statement of Changes in Equity - CAD ($) $ in Millions |
Total |
Contributed surplus [member] |
Retained earnings [member] |
Accumulated other comprehensive income [member] |
Accumulated other comprehensive income [member]
Reserve of cash flow hedges [member]
|
Accumulated other comprehensive income [member]
Reserve of change in fair value of financial liability attributable to change in credit risk of liability [member]
|
Accumulated other comprehensive income [member]
Reserve of exchange differences on translation [member]
|
Accumulated other comprehensive income [member]
Financial assets at fair value through other comprehensive income [member]
|
Accumulated other comprehensive income [member]
Equity securities at fair value through other comprehensive income [member]
|
Common shares [member]
Retained earnings [member]
|
Common shares [member]
Issued capital [member]
|
Common shares [member]
Treasury shares [member]
|
Preferred shares and other equity instruments [member] |
Preferred shares and other equity instruments [member]
Retained earnings [member]
|
Preferred shares and other equity instruments [member]
Issued capital [member]
|
Preferred shares and other equity instruments [member]
Treasury shares [member]
|
| Balance at beginning of period at Oct. 31, 2024 |
|
$ 204
|
$ 70,826
|
|
$ (2,924)
|
$ (22)
|
$ 12,893
|
$ (208)
|
$ 35
|
|
$ 25,373
|
$ (17)
|
|
|
$ 10,888
|
$ (18)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
4
|
|
|
|
|
|
|
|
|
131
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
130
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
750
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(663)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(9,606)
|
|
|
|
(1,460)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(850)
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
9,531
|
|
|
|
1,476
|
| Net premium (discount) on sale of treasury instruments |
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
17,258
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
$ (5,449)
|
|
|
|
$ (374)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(3,469)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
$ (28)
|
|
(28)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
(13)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
171
|
|
|
|
|
|
|
170
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
1
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
90
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
13
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(13)
|
|
|
|
|
(13)
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(328)
|
|
|
|
|
|
(328)
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
1,030
|
|
|
|
1,030
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
1,870
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Jul. 31, 2025 |
125,394
|
243
|
78,749
|
$ 10,737
|
(1,894)
|
(35)
|
12,565
|
(37)
|
138
|
|
24,971
|
(92)
|
$ 10,788
|
|
10,788
|
(2)
|
| Balance at beginning of period at Apr. 30, 2025 |
|
199
|
78,640
|
|
(1,078)
|
(1)
|
12,381
|
(352)
|
82
|
|
25,136
|
(26)
|
|
|
11,138
|
(28)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
1
|
|
|
|
|
|
|
|
|
62
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(227)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(3,222)
|
|
|
|
(73)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(350)
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
3,156
|
|
|
|
99
|
| Net premium (discount) on sale of treasury instruments |
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
3,336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
(1,798)
|
|
|
|
(88)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(1,334)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
(17)
|
|
(17)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
315
|
|
|
|
|
|
|
315
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
0
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
66
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
(10)
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(34)
|
|
|
|
|
(34)
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
184
|
|
|
|
|
|
184
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(816)
|
|
|
|
(816)
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Jul. 31, 2025 |
125,394
|
243
|
78,749
|
10,737
|
(1,894)
|
(35)
|
12,565
|
(37)
|
138
|
|
24,971
|
(92)
|
10,788
|
|
10,788
|
(2)
|
| Balance at beginning of period at Oct. 31, 2025 |
127,827
|
285
|
78,320
|
|
(769)
|
(28)
|
13,242
|
283
|
146
|
|
24,727
|
0
|
|
|
11,625
|
(4)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
70
|
|
|
|
|
|
|
|
|
202
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,250
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(780)
|
|
|
|
|
|
| Purchase of shares |
|
|
|
|
|
|
|
|
|
|
|
(9,162)
|
|
|
|
(2,537)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
9,143
|
|
|
|
2,495
|
| Net premium (discount) on sale of treasury instruments |
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
12,909
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
(5,437)
|
|
|
|
(397)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(6,665)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
72
|
|
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
36
|
|
|
|
|
|
|
35
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
1
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
112
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
(83)
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(7)
|
|
|
|
|
(7)
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(123)
|
|
|
|
|
|
(123)
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(2,038)
|
|
|
|
(2,038)
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Jul. 31, 2026 |
127,015
|
403
|
78,882
|
10,771
|
(2,807)
|
(35)
|
13,119
|
319
|
175
|
|
24,149
|
(19)
|
12,875
|
|
12,875
|
(46)
|
| Balance at beginning of period at Apr. 30, 2026 |
|
361
|
78,295
|
|
(2,019)
|
(31)
|
11,343
|
338
|
171
|
|
24,309
|
(60)
|
|
|
11,625
|
(14)
|
| Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of stock options, net of options exercised |
|
30
|
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
| Shares issued as a result of dividend reinvestment plan |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
| Issue of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,250
|
|
| Purchase of shares for cancellation and other |
|
|
|
|
|
|
|
|
|
|
(212)
|
|
|
|
|
|
| Purchase of shares |
(2,400)
|
|
|
|
|
|
|
|
|
|
|
(2,949)
|
|
|
|
(2,022)
|
| Purchase of shares and other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
| Sale of shares |
|
|
|
|
|
|
|
|
|
|
|
2,990
|
|
|
|
1,990
|
| Net premium (discount) on sale of treasury instruments |
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income attributable to equity instrument holders |
|
|
4,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred dividends and distributions on other equity instruments |
|
|
|
|
|
|
|
|
|
$ (1,840)
|
|
|
|
$ (94)
|
|
|
| Net premium on repurchase of common shares and redemption of preferred shares and other equity instruments |
|
|
(2,182)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share and other equity instrument issue expenses |
|
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remeasurement gain/(loss) on employee benefit plans |
44
|
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Realized gain/(loss) on equity securities designated at fair value through other comprehensive income |
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(19)
|
|
|
|
|
|
|
(19)
|
|
|
|
|
|
|
|
|
| Allowance for credit losses |
0
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
|
| Reclassification of loss/(gain) to retained earnings |
|
|
|
|
|
|
|
|
(48)
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(4)
|
|
|
|
|
(4)
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
1,776
|
|
|
|
|
|
1,776
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(788)
|
|
|
|
(788)
|
|
|
|
|
|
|
|
|
|
|
|
| Share of accumulated other comprehensive income (loss) from investment in Schwab |
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance at end of period at Jul. 31, 2026 |
$ 127,015
|
$ 403
|
$ 78,882
|
$ 10,771
|
$ (2,807)
|
$ (35)
|
$ 13,119
|
$ 319
|
$ 175
|
|
$ 24,149
|
$ (19)
|
$ 12,875
|
|
$ 12,875
|
$ (46)
|